AbbVie Focuses On Humira’s Formulary Positioning Ahead Of Biosimilars

 
• By Joseph Haas
AbbVie exterior
AbbVie talked about US formulary positioning for Humira post-patent expiry • Source: Alamy

More from Earnings

More from Business